Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024
Compare Balance Sheet Results of Bio Medica Lab
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.18
13.17
-3.99
-30.30%
Share Warrants & Outstandings
Total Reserve
5.55
120.69
-115.14
-95.40%
Shareholder's Funds
14.73
133.86
-119.13
-89.00%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.31
6.45
2,080.65%
Secured Loans
6.76
0.31
6.45
2,080.65%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.22
-1.10
0.88
80.00%
Other Long Term Liabilities
0.63
0.00
0.63
0.00%
Long Term Trade Payables
0.00
2.28
-2.28
-100.00%
Long Term Provisions
0.00
2.68
-2.68
-100.00%
Total Non-Current Liabilities
7.17
4.04
3.13
77.48%
Current Liabilities
Trade Payables
4.28
16.39
-12.11
-73.89%
Other Current Liabilities
4.47
1.27
3.20
251.97%
Short Term Borrowings
8.25
5.26
2.99
56.84%
Short Term Provisions
0.00
1.36
-1.36
-100.00%
Total Current Liabilities
16.99
24.28
-7.29
-30.02%
Total Liabilities
38.90
162.18
-123.28
-76.01%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.31
30.76
-19.45
-63.23%
Less: Accumulated Depreciation
3.85
12.86
-9.01
-70.06%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.46
17.90
-10.44
-58.32%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
14.83
-14.83
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.21
0.00
0.21
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
5.17
-5.17
-100.00%
Other Non Current Assets
0.13
35.54
-35.41
-99.63%
Total Non-Current Assets
7.81
73.45
-65.64
-89.37%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
18.14
45.90
-27.76
-60.48%
Sundry Debtors
4.10
34.80
-30.70
-88.22%
Cash and Bank
0.01
4.41
-4.40
-99.77%
Other Current Assets
1.28
0.07
1.21
1,728.57%
Short Term Loans and Advances
7.57
3.55
4.02
113.24%
Total Current Assets
31.09
88.73
-57.64
-64.96%
Net Current Assets (Including Current Investments)
14.10
64.45
-50.35
-78.12%
Total Current Assets Excluding Current Investments
31.09
88.73
-57.64
-64.96%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
38.90
162.18
-123.28
-76.01%
Contingent Liabilities
0.05
0.77
-0.72
-93.51%
Total Debt
15.01
5.31
9.70
182.67%
Book Value per share (adjusted)
16.05
101.63
-85.58
-84.21%
Annual - Borrowings
Borrowings 15.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 7.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 31.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024






